Occudo Quantitative Strategies LP Aspira Women'S Health Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.38 - $1.07 $262 - $739	-691 Reduced 1.31%	51,995 $19,000
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $1,178 - $3,212	-2,947 Reduced 5.3%	52,686 $31,000
Q4 2021 Feb 14, 2022	SELL	$1.63 - $3.43 $1,882 - $3,961	-1,155 Reduced 2.03%	55,633 $98,000
Q3 2021 Nov 15, 2021	BUY	$3.19 - $5.48 $14,619 - $25,114	4,583 Added 8.78%	56,788 $185,000
Q2 2021 Aug 16, 2021	BUY	$4.78 - $6.84 $249,539 - $357,082	52,205 New	52,205 $293,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $185M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.